Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Imagine Eyes is a French medical technology company that pioneered the use of adaptive optics for high-resolution retinal imaging. The company's flagship product, the rtx1 Adaptive Optics Retinal Camera, allows clinicians to observe the living retina at a cellular level, providing unprecedented detail of photoreceptors, microvasculature, and the retinal pigment epithelium. This technology is utilized globally by leading ophthalmology centers and pharmaceutical companies to improve the diagnosis and monitoring of retinal diseases and to accelerate the development of new therapies. By bridging the gap between clinical examination and histology, Imagine Eyes enables more precise patient management and more sensitive clinical trial endpoints.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Imagine Eyes.